VTYX MEXC RealStocks
Own real VTYX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 10:11:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Ventyx Biosciences, Inc. (VTYX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Ventyx Biosciences, Inc. (VTYX) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing VTYX before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, Ventyx Biosciences, Inc. (VTYX) moved from $13.96 to $14.00, representing a gain of 0.29% ($0.04).
The stock traded between $13.94 and $14.00 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 4.61 million shares, up versus the previous seven-day period, indicating higher trading activity.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 81 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Ventyx Biosciences, Inc. (VTYX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VTYX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VTYX shares and USD.
VTYX Shares to USD
1.00 VTYX shares = 0 USD
Calculations are estimates based on the latest available price and are for reference only.